The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease
Neurology International June 23, 2022 Islam Mohammad Shehata, Waniyah Masood, Nouran Nemr et al. 41 citations
Depression is a leading cause of disability globally, with a prevalence of 3.8% among the whole population, 5% of the adult population, and 5.7% of the elderly population over 60 years of age. There is evidence that depression is linked to certain neurodegenerative diseases, one being Alzheimer’s disease (AD). The efficacy of conventional antidepressants to treat depression in AD is...